Skip to content

Drug interactions

Brimonidine + Buprenorphine long-acting

Severity: Moderate

Brimonidine and Buprenorphine long-acting: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Brimonidine is an alpha-2 agonist that can cause drowsiness and CNS depression through systemic absorption. Combined with long-acting injectable buprenorphine, sedation may be increased, though ophthalmic dosing carries limited systemic exposure.

What this interaction means in plain words

Brimonidine and Buprenorphine long-acting can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Evidence level: Low

Why it happens

Additive CNS depression from alpha-2 adrenergic agonism and opioid receptor agonism.

What to do

Monitor sedation level and respiratory status, particularly in children, older adults and those with respiratory disease. Counsel on additive drowsiness.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Brimonidine and Buprenorphine long-acting, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Brimonidine with Buprenorphine long-acting?

MediHelp rates the interaction as moderate. Brimonidine and Buprenorphine long-acting can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Brimonidine is an alpha-2 agonist that can cause drowsiness and CNS depression through systemic absorption. Combined with long-acting injectable buprenorphine, sedation may be increased, though ophthalmic dosing carries limited systemic exposure.

How serious is the interaction between Brimonidine and Buprenorphine long-acting?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor sedation level and respiratory status, particularly in children, older adults and those with respiratory disease. Counsel on additive drowsiness.

What other medicines interact with Brimonidine?

MediHelp also lists interactions of Brimonidine with, for example, Isocarboxazid, Linezolid, Phenelzine. The full list is on the Brimonidine page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in